Galectin Therapeutics reported $-8597000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Galectin Therapeutics GALT:US USD -8597000 1.02M
Gilead Sciences GILD:US USD 2.52B 357M
Idera Pharmaceuticals IDRA:US USD 9.14M 14.44M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Merk MRK:US USD 4.89B 560M
Regulus Therapeutics RGLS:US USD -7551000 293K
Vital Therapies VTL:US USD -21224000 677K
YTE INCY:US USD 178.62M 401K